Within 21 days, RCC-41-PDX-1/CD132+ grew forming small spheroids with an efficiency of about 40% at the limiting dilution of 102 cells per well, while no spheres developed at the limiting dilution of 1 cell/well. This evidence concerns the gene IL2RG and renal cell carcinoma.